Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,362.00
-30.00 (-2.16%)
Apr 17, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 6.96 billion as of April 17, 2026. Its market cap has decreased by -22.30% in one year.
Market Cap
6.96B
Enterprise Value
6.61B
Revenue
5.07B
Ranking
n/a
PE Ratio
12.50
Stock Price
1,362.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 6.96B, a decrease of -41.42%. That is a compound annual growth rate of -23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.96B | -8.53% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 8.81B |
| Carna Biosciences | 8.29B |
| MEDINET | 7.99B |
| CellSource | 7.96B |
| StemCell Institute | 7.95B |
| ADR120S | 7.36B |
| Chiome Bioscience | 7.30B |
| PRISM BioLab Co.,LTD | 7.20B |